Matches in Wikidata for { <http://www.wikidata.org/entity/Q58848980> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- Q58848980 description "A clinical trial related to cancer immunotherapy, retrieved from clinicaltrials.gov" @default.
- Q58848980 description "klinisch onderzoek" @default.
- Q58848980 name "Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy" @default.
- Q58848980 name "Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy" @default.
- Q58848980 name "Provenge®" @default.
- Q58848980 type Item @default.
- Q58848980 label "Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy" @default.
- Q58848980 label "Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy" @default.
- Q58848980 label "Provenge®" @default.
- Q58848980 prefLabel "Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy" @default.
- Q58848980 prefLabel "Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy" @default.
- Q58848980 prefLabel "Provenge®" @default.
- Q58848980 P1050 Q58848980-332364C5-4E03-4473-9D70-D8782738FE66 @default.
- Q58848980 P1050 Q58848980-d7233e73-4dcf-6725-96d0-cb00fc36af89 @default.
- Q58848980 P1132 Q58848980-20e30bd3-4c3d-4ca0-6b96-9ebd27834126 @default.
- Q58848980 P1476 Q58848980-be2bae92-4df6-0ac3-f464-8cd2e5fed2cc @default.
- Q58848980 P2899 Q58848980-25B30CBB-18CD-45A8-B403-87F5059E8D93 @default.
- Q58848980 P3098 Q58848980-7EA8DC3C-4C05-4FA1-8E2B-25EDD0475A79 @default.
- Q58848980 P31 Q58848980-9A056490-190D-41E5-8B34-20F5DB3FF030 @default.
- Q58848980 P4844 Q58848980-f3b736f1-403f-0b47-e132-e3dcd4ea137f @default.
- Q58848980 P580 Q58848980-fe7df4bc-4606-c74a-ffaa-33e0c17ff951 @default.
- Q58848980 P582 Q58848980-4dec9ff4-4a9f-882e-46d7-2fad1b72bded @default.
- Q58848980 P6099 Q58848980-3d4cb277-4237-c356-374a-30309b2f5fed @default.
- Q58848980 P6153 Q58848980-06008A9D-038A-4119-A605-B60D70A80325 @default.
- Q58848980 P6153 Q58848980-060C6D74-1E27-4996-B8F3-70F1E907EF25 @default.
- Q58848980 P6153 Q58848980-638E74E9-EA28-46F5-9D7E-D33BB067D5E1 @default.
- Q58848980 P6153 Q58848980-64A27B38-2C8F-4FD7-9EDE-0E67F4C0DB82 @default.
- Q58848980 P6153 Q58848980-66D09D7D-A2CA-4FA9-AD14-2D614CFBEF36 @default.
- Q58848980 P6153 Q58848980-6A8D762C-C91E-45A1-87AD-1EF084022412 @default.
- Q58848980 P6153 Q58848980-6B2D7F4B-544B-4F92-A6E1-7EDD3ACE6D4B @default.
- Q58848980 P6153 Q58848980-76537689-4690-4F83-BDCE-DA31F3E7BDA8 @default.
- Q58848980 P6153 Q58848980-76F176B9-A745-4284-8294-4DE9D37707DB @default.
- Q58848980 P6153 Q58848980-786A22EE-B4BF-4EA8-8261-AFA33ED02C86 @default.
- Q58848980 P6153 Q58848980-79B9913C-97C7-4894-A5AC-C87BD0E0885D @default.
- Q58848980 P6153 Q58848980-95D88E39-C329-43B9-8208-E2E88A73D601 @default.
- Q58848980 P6153 Q58848980-9942BE77-76EF-4059-9BF3-C215341536CD @default.
- Q58848980 P6153 Q58848980-A3E25E46-4F4D-4625-880D-382A920A64EF @default.
- Q58848980 P6153 Q58848980-CAB74A9F-DF9F-495D-8BCC-4A76696EB01B @default.
- Q58848980 P6153 Q58848980-CBE31A5D-020F-4257-A82A-5EF1D91284BF @default.
- Q58848980 P6153 Q58848980-CD86C64D-9F25-4D0B-895D-850B945AAA37 @default.
- Q58848980 P6153 Q58848980-CF2EF0DF-890B-47A6-B5AE-3A1BA0864565 @default.
- Q58848980 P6153 Q58848980-D0EF6266-555D-4427-9073-FB73BFBC1732 @default.
- Q58848980 P6153 Q58848980-D759436B-40C5-454B-B9BC-2FD2BFCDD30C @default.
- Q58848980 P6153 Q58848980-DD7A695B-073A-435D-B0AE-B01C4AECD062 @default.
- Q58848980 P6153 Q58848980-E368F75F-81E9-454A-AB66-1F3CCC1EC95D @default.
- Q58848980 P6153 Q58848980-FBD4F66F-1F8F-451D-8972-67A7A76E1226 @default.
- Q58848980 P8363 Q58848980-B66CED79-C89C-4166-AA57-3A7A6344D24C @default.
- Q58848980 P859 Q58848980-3d1e968b-4093-8d3e-8e2d-593d4421a6aa @default.
- Q58848980 P921 Q58848980-D08A5986-DE61-44B9-B8AE-7F60A32BFA96 @default.
- Q58848980 P1050 Q55779807 @default.
- Q58848980 P1050 Q56014511 @default.
- Q58848980 P1132 "+512" @default.
- Q58848980 P1476 "A Randomized, Double Blind, Placebo Controlled Phase 3 Trial of Immunotherapy With Autologous Antigen Presenting Cells Loading With PA2024 (Provenge(R), APC8015) in Men With Metastatic Androgen Independent Prostatic Adenocarcinoma" @default.
- Q58848980 P2899 "+18" @default.
- Q58848980 P3098 "NCT00065442" @default.
- Q58848980 P31 Q30612 @default.
- Q58848980 P4844 Q424057 @default.
- Q58848980 P580 "2003-07-01T00:00:00Z" @default.
- Q58848980 P582 "2009-01-01T00:00:00Z" @default.
- Q58848980 P6099 Q42824827 @default.
- Q58848980 P6153 Q1130172 @default.
- Q58848980 P6153 Q1159198 @default.
- Q58848980 P6153 Q1433199 @default.
- Q58848980 P6153 Q153265 @default.
- Q58848980 P6153 Q1535116 @default.
- Q58848980 P6153 Q1537759 @default.
- Q58848980 P6153 Q16932830 @default.
- Q58848980 P6153 Q1950740 @default.
- Q58848980 P6153 Q219563 @default.
- Q58848980 P6153 Q238101 @default.
- Q58848980 P6153 Q2892284 @default.
- Q58848980 P6153 Q30269598 @default.
- Q58848980 P6153 Q30270311 @default.
- Q58848980 P6153 Q30270635 @default.
- Q58848980 P6153 Q30279912 @default.
- Q58848980 P6153 Q30288725 @default.
- Q58848980 P6153 Q33122159 @default.
- Q58848980 P6153 Q4115972 @default.
- Q58848980 P6153 Q4117596 @default.
- Q58848980 P6153 Q49210 @default.
- Q58848980 P6153 Q56582915 @default.
- Q58848980 P6153 Q7934403 @default.
- Q58848980 P6153 Q838330 @default.
- Q58848980 P8363 Q78089383 @default.
- Q58848980 P859 Q5256667 @default.
- Q58848980 P921 Q2012719 @default.